Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiencyClaudia Wehr, Marta Rizzi, Manfred Hoenig et al.|Journal of Allergy and Clinical Immunology|2015Cited by 141
Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03Christian Taverna, Michele Ghielmini, Giovanni Martinelli et al.|Journal of Clinical Oncology|2015Cited by 63